Poly Medicure Share Price
Start SIP in Poly Medicure
Start SIPPoly Medicure Performance
Day Range
- Low 2,810
- High 2,860
52 Week Range
- Low 1,361
- High 3,358
- Open Price2,825
- Previous Close2,815
- Volume191499
Poly Medicure Investment Rating
-
Master Rating:
-
Poly Medicure Ltd. is a leading Indian manufacturer of medical devices, specializing in infusion therapy, dialysis, urology, and diagnostics. With 8 global manufacturing facilities, it delivers high-quality healthcare products to patients and healthcare providers worldwide.
Poly Medicure has an operating revenue of Rs. 1,522.46 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 25% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 47% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 5 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.
Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 402 | 367 | 361 | 321 | 320 | 306 | 293 |
Operating Expenses Qtr Cr | 290 | 266 | 264 | 236 | 237 | 220 | 212 |
Operating Profit Qtr Cr | 113 | 101 | 97 | 84 | 83 | 85 | 82 |
Depreciation Qtr Cr | 20 | 19 | 16 | 16 | 15 | 15 | 15 |
Interest Qtr Cr | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
Tax Qtr Cr | 30 | 24 | 23 | 21 | 19 | 20 | 16 |
Net Profit Qtr Cr | 87 | 72 | 71 | 61 | 59 | 61 | 57 |
Poly Medicure Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹2,657.88
- 50 Day
- ₹2,477.31
- 100 Day
- ₹2,282.79
- 200 Day
- ₹2,023.32
- 20 Day
- ₹2,602.53
- 50 Day
- ₹2,486.82
- 100 Day
- ₹2,253.86
- 200 Day
- ₹1,927.66
Poly Medicure Resistance and Support
Resistance | |
---|---|
First Resistance | 2,862.55 |
Second Resistance | 2,885.85 |
Third Resistance | 2,912.10 |
RSI | 61.52 |
MFI | 67.40 |
MACD Single Line | 104.66 |
MACD | 134.92 |
Support | |
---|---|
First Support | 2,813.00 |
Second Support | 2,786.75 |
Third Supoort | 2,763.45 |
Poly Medicure Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 195,038 | 11,842,707 | 60.72 |
Week | 460,213 | 12,315,289 | 26.76 |
1 Month | 264,958 | 7,516,861 | 28.37 |
6 Month | 177,280 | 8,954,403 | 50.51 |
Poly Medicure Result Highlights
Poly Medicure Synopsis
NSE-Medical-Systems/Equip
Poly Medicure Ltd. is a prominent medical device company, recognized for manufacturing and exporting high-quality healthcare products. With 8 state-of-the-art manufacturing facilities across India, Italy, China, and Egypt, the company specializes in infusion therapy, dialysis, urology, diagnostics, and central venous access catheters. Serving healthcare providers for over two decades, Poly Medicure emphasizes innovation, safety, and quality in its product line. It has been awarded the “Medical Devices Company of the Year 2018” by the Government of India and is the largest exporter of medical devices from India for six consecutive years, ensuring high standards of patient care globally.Market Cap | 28,526 |
Sales | 1,452 |
Shares in Float | 3.75 |
No of funds | 217 |
Yield | 0.1 |
Book Value | 18.53 |
U/D Vol ratio | 2.2 |
LTDebt / Equity | 1 |
Alpha | 0.24 |
Beta | 0.72 |
Poly Medicure Shareholding Pattern
Owner Name | Sep-24 | Jun-24 | Mar-24 |
---|---|---|---|
Promoters | 62.56% | 66.03% | 53.15% |
Mutual Funds | 7.35% | 6.29% | 4.99% |
Insurance Companies | 3.06% | 2.31% | 2.01% |
Foreign Portfolio Investors | 11.88% | 9.91% | 12.37% |
Individual Investors | 10.13% | 11.37% | 11.34% |
Others | 5.02% | 4.09% | 16.14% |
Poly Medicure Management
Name | Designation |
---|---|
Mr. Devendra Raj Mehta | Chairman |
Mr. Himanshu Baid | Managing Director |
Mr. Rishi Baid | Joint Managing Director |
Mr. Jugal Kishore Baid | Non Executive Director |
Mrs. Mukulika Baid | Non Executive Director |
Mr. Alessandro Balboni | Non Executive Director |
Dr. Shailendra Raj Mehta | Ind. Non-Executive Director |
Dr. Ambrish Mithal | Ind. Non-Executive Director |
Dr. Sandeep Bhargava | Ind. Non-Executive Director |
Mr. Vimal Bhandari | Ind. Non-Executive Director |
Mr. Amit Khosla | Ind. Non-Executive Director |
Ms. Sonal Mattoo | Ind. Non-Executive Director |
Poly Medicure Forecast
Price Estimates
Poly Medicure Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-10-28 | Quarterly Results & ESOP | |
2024-07-22 | Quarterly Results | |
2024-06-29 | Others | Inter alia, to consider and finalize the terms and condition and approve the modes of fund raising. per share(40%)Interim Dividend |
2024-05-17 | Audited Results & Final Dividend | |
2024-03-08 | Others | Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). per share(40%)Interim Dividend |
Poly Medicure FAQs
What is Share Price of Poly Medicure ?
Poly Medicure share price is ₹2,839 As on 07 November, 2024 | 02:23
What is the Market Cap of Poly Medicure ?
The Market Cap of Poly Medicure is ₹28768.9 Cr As on 07 November, 2024 | 02:23
What is the P/E ratio of Poly Medicure ?
The P/E ratio of Poly Medicure is 97.6 As on 07 November, 2024 | 02:23
What is the PB ratio of Poly Medicure ?
The PB ratio of Poly Medicure is 19.6 As on 07 November, 2024 | 02:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.